E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for AntriaBio, Inc. > News item
Published on 7/1/2013 in the Prospect News PIPE Daily.

AntriaBio intends to price $12 million private placement of stock

Deal funds general operations, development of lead product candidate

By Devika Patel

Knoxville, Tenn., July 1 - AntriaBio, Inc. said it will price a $1.5 million private placement of stock.

Proceeds will be used for general operations, including development of AB101, AntriaBio's lead product candidate.

The biopharmaceutical company is based in Menlo Park, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.